4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0000950170-24-027249
SVP, Business Development sold 17,411 shares at an average $4.21 ($73,379)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Birznieks Gunther SVP, Business Development | 2024-03-04 | Sale | −8,727 | $4.30 | $37,495 | 322,253 | D: show line 1 in the form |
| Birznieks Gunther SVP, Business Development | 2024-03-05 | Sale | −8,684 | $4.13 | $35,884 | 313,569 | D: show line 2 in the form |
| Open-market sales · 17,411 sh · avg $4.21 · $73,379 | |||||||
Loading xslF345X05/ownership.xml…